Commonwealth Equity Services’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-21,442
Closed -$244K 3790
2022
Q4
$244K Buy
+21,442
New +$318K ﹤0.01% 3049
2022
Q1
Sell
-8,393
Closed -$381K 3720
2021
Q4
$381K Sell
8,393
-11,159
-57% -$582K ﹤0.01% 2757
2021
Q3
$1.24M Buy
19,552
+4,367
+29% +$333K ﹤0.01% 1766
2021
Q2
$1.39M Sell
15,185
-166
-1% -$13.2K ﹤0.01% 1675
2021
Q1
$1.04M Buy
15,351
+11,971
+354% +$929K ﹤0.01% 1758
2020
Q4
$244K Buy
+3,380
New +$196K ﹤0.01% 2749
2018
Q1
Sell
-10,250
Closed -$75K 2724
2017
Q4
$75K Buy
+10,250
New +$63.9K ﹤0.01% 2535

Other funds holding CDNA

Commonwealth Equity Services's CDNA Position: Q1 2023 in Review

Commonwealth Equity Services sold out of CareDx (CDNA) in Q1 2023, closing a stake of 21,442 shares — an estimated $244K sold.

Commonwealth Equity Services first reported a position in CDNA in Q4 2017 and held it in 7 quarters. The position peaked at $1.39M in Q2 2021. 156 funds tracked by Wall St. Rank hold CDNA as of Q1 2023.

  • Commonwealth Equity Services reported no remaining CareDx position as of Q1 2023 after selling out during the quarter.
  • Commonwealth Equity Services sold 21,442 CareDx shares in Q1 2023, an estimated $244K.
  • Commonwealth Equity Services first reported a position in CareDx in Q4 2017 and held it in 7 quarters.
  • Commonwealth Equity Services's CareDx position peaked at $1.39M in Q2 2021.
  • 156 funds tracked by Wall St. Rank held CareDx as of Q1 2023.

Based on Commonwealth Equity Services's 13F filing for Q1 2023, filed 11 May 2023.